{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:44:31Z","timestamp":1786635871998,"version":"build-2736575974"},"reference-count":112,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0019-509x.63025","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T04:10:09Z","timestamp":1273032609000},"page":"206","source":"Crossref","is-referenced-by-count":9,"title":["Papillary thyroid carcinoma: Debate at rest"],"prefix":"10.4103","volume":"47","author":[{"given":"AA","family":"Sonkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rajamanickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.63025-1","first-page":"2164","volume-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"key-10.4103\/0019-509X.63025-2","first-page":"1093","volume-title":"Thyroid cancer: Is the incidence still increasing?","author":"Hodgson","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"key-10.4103\/0019-509X.63025-3","first-page":"1690","volume-title":"Distinct pattern of RET oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children","author":"Nikiforov","year":"1997","journal-title":"Cancer Res"},{"key":"key-10.4103\/0019-509X.63025-4","unstructured":"Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: Prevalence by palpation and ultrasonography. Arch Intern Med 1994154:1338-40"},{"key":"key-10.4103\/0019-509X.63025-5","first-page":"683","volume-title":"Thyroid gland: US screening in a random adult population","author":"Brander","year":"1991","journal-title":"Radiology"},{"key":"key-10.4103\/0019-509X.63025-6","first-page":"553","volume-title":"Management of a solitary thyroid nodule","author":"Mazzaferri","year":"1993","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.63025-7","first-page":"1941","volume-title":"Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features","author":"Papini","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-8","first-page":"325","volume-title":"Fine-needle aspiration cytology of the thyroid: An appraisal","author":"Cramer","year":"2000","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.63025-9","first-page":"401","volume-title":"Sonographic Imaging of Thyroid Nodules and Cervical Lymph Nodes","author":"Fish","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/0019-509X.63025-10","first-page":"3411","volume-title":"Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography","author":"Frates","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-11","first-page":"192","volume-title":"Evaluating the degree of conformity of papillary carcinoma and follicular carcinoma to the reported ultrasonographic findings of malignant thyroid tumor","author":"Jeh","year":"2007","journal-title":"Korean J Radiol"},{"key":"key-10.4103\/0019-509X.63025-12","first-page":"1027","volume-title":"Sonographic features of benign nodules","author":"Wienke","year":"2003","journal-title":"J Ultrasound Med"},{"key":"key-10.4103\/0019-509X.63025-13","first-page":"368","volume-title":"Thyroid calcifications: Sonographic patterns and incidence of cancer","author":"Taki","year":"2004","journal-title":"Clin Imaging"},{"key":"key-10.4103\/0019-509X.63025-14","first-page":"157","volume-title":"Sonography of thyroid nodules: A \u2032\u2032classic pattern\u2032\u2032 diagnostic approach","author":"Reading","year":"2005","journal-title":"Ultrasound Q"},{"key":"key-10.4103\/0019-509X.63025-15","first-page":"1083","volume-title":"Common and uncommon sonographic features of papillary thyroid carcinoma","author":"Chan","year":"2003","journal-title":"J Ultrasound Med"},{"key":"key-10.4103\/0019-509X.63025-16","first-page":"689","volume-title":"Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology?","author":"Cappelli","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0019-509X.63025-17","first-page":"2917","volume-title":"Elastography: New developments in ultrasound for predicting malignancy in thyroid nodules","author":"Rago","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-18","first-page":"1139","volume-title":"Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period","author":"Hay","year":"1992","journal-title":"Surgery"},{"key":"key-10.4103\/0019-509X.63025-19","first-page":"1467","volume-title":"Papillary microcarcinoma of the thyroid.179 cases reported since 1973","author":"Tourniaire","year":"1998","journal-title":"Presse Med"},{"key":"key-10.4103\/0019-509X.63025-20","first-page":"255","volume-title":"Papillary microcarcinoma: Clinical study and prognosis","author":"Rodriguez","year":"1997","journal-title":"Eur J Surg"},{"key":"key-10.4103\/0019-509X.63025-21","unstructured":"Rosai J, Carcangiu ML, De Lellis RA. Papillary Carcinoma. In: Atlas of tumor pathology. Tumors of the thyroid gland. Washington; 1992. p. 96-100."},{"key":"key-10.4103\/0019-509X.63025-22","first-page":"2043","volume-title":"Micropapillary thyroid cancer: Should we aspirate all nodules regardless of size?","author":"Burman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-23","first-page":"261","volume-title":"Challenges in neck ultrasonography: lymphadenopathy and parathyroid glands","author":"Frasoldati","year":"2004","journal-title":"Endocr Pract"},{"key":"key-10.4103\/0019-509X.63025-24","first-page":"1364","volume-title":"The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies","author":"Boi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-25","first-page":"109","volume-title":"American Thyroid Association Guidelines Taskforce.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer","author":"Cooper","year":"2006","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-26","first-page":"1385","volume-title":"Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma","author":"Ros\u03b1rio","year":"2005","journal-title":"J Ultrasound Med"},{"key":"key-10.4103\/0019-509X.63025-27","first-page":"946","volume-title":"Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer","author":"Kouvaraki","year":"2003","journal-title":"Surgery"},{"key":"key-10.4103\/0019-509X.63025-28","first-page":"110","volume-title":"Incidence of metastatic well differentiated thyroid cancer in cervical lymph nodes","author":"Wang","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key-10.4103\/0019-509X.63025-29","first-page":"1258","volume-title":"Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma","author":"Gonz\u03b1lez","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key-10.4103\/0019-509X.63025-30","doi-asserted-by":"crossref","unstructured":"Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol 2009;99:28-31.","DOI":"10.1002\/jso.21164"},{"key":"key-10.4103\/0019-509X.63025-31","first-page":"411","volume-title":"Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: Comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography","author":"Kim","year":"2008","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-32","unstructured":"Myers EN, Suen JY. Cancer of the Head and Neck. Philadelphia, Pa: WB Saunders Co; 1996."},{"key":"key-10.4103\/0019-509X.63025-33","first-page":"692","volume-title":"Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid","author":"Shaha","year":"1996","journal-title":"Am J Surg"},{"key":"key-10.4103\/0019-509X.63025-34","first-page":"418","volume-title":"Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer","author":"Mazzaferri","year":"1994","journal-title":"Am J Med"},{"key":"key-10.4103\/0019-509X.63025-35","first-page":"1053","volume-title":"Papillary carcinoma of the thyroid, I: Developing pattern of metastasis","author":"Noguchi","year":"1970","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.63025-36","first-page":"399","volume-title":"Lymph node metastasis from 259 papillary thyroid microcarcinomas: Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection","author":"Wada","year":"2003","journal-title":"Ann Surg"},{"key":"key-10.4103\/0019-509X.63025-37","first-page":"970","volume-title":"Localization of cervical node metastasis of papillary thyroid carcinoma","author":"Miralli\u03b9","year":"1999","journal-title":"World J Surg"},{"key":"key-10.4103\/0019-509X.63025-38","first-page":"1285","volume-title":"Evidence-based surgical management of substernal goiter","author":"White","year":"2008","journal-title":"World J Surg"},{"key":"key-10.4103\/0019-509X.63025-39","first-page":"1241","volume-title":"Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid","author":"Sivanandan","year":"2001","journal-title":"Br J Surg"},{"key":"key-10.4103\/0019-509X.63025-40","first-page":"1275","volume-title":"Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: A common occurrence","author":"Pingpank","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key-10.4103\/0019-509X.63025-41","first-page":"366","volume-title":"Staging systems for papillary thyroid carcinoma - A review and comparison","author":"Lang","year":"2007","journal-title":"Ann Surg"},{"key":"key-10.4103\/0019-509X.63025-42","first-page":"1057","volume-title":"Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989","author":"Hay","year":"1993","journal-title":"Surgery"},{"key":"key-10.4103\/0019-509X.63025-43","doi-asserted-by":"crossref","unstructured":"Greene FL, Page DL, Fleming ID, Fritz GA, Balch MC, Heller GD et al. AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors, 6th ed. New York: Springer-Verlag, 2002.","DOI":"10.1007\/978-1-4757-3656-4"},{"key":"key-10.4103\/0019-509X.63025-44","first-page":"1033","volume-title":"A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group","author":"Byar","year":"1979","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0019-509X.63025-45","unstructured":"Sherman SI, Ball DW, Byrd D, Clark OH, Daniels GH, Tuttle RM et al. NCCN Guidelines. Version 2009, as viewed at the National Comprehensive Cancer Network website on 6 th June 2009."},{"key":"key-10.4103\/0019-509X.63025-46","first-page":"375","volume-title":"Extent of surgery affects survival after papillary thyroid carcinoma","author":"Bilimoria","year":"2007","journal-title":"Ann Surg"},{"key":"key-10.4103\/0019-509X.63025-47","first-page":"879","volume-title":"Papillary Thyroid Carcinoma managed at the Mayo clinic during six decades (1940-1999): Temporal trends in initial therapy and long term out come in 2444 consecutively treated patients","author":"Hay","year":"2002","journal-title":"World J Surg"},{"key":"key-10.4103\/0019-509X.63025-48","first-page":"77","volume-title":"Use of radioactive iodine for thyroid remnant ablation in well differentiated thyroid carcinoma to replace thyroid reoperation","author":"Lin","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"key-10.4103\/0019-509X.63025-49","first-page":"5362","volume-title":"Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas","author":"Rouxel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-50","first-page":"1130","volume-title":"1992 Follicular Thyroid Carcinoma with capsular invasion alone: A non threatening malignancy","author":"van","year":"1992","journal-title":"Surgery"},{"key":"key-10.4103\/0019-509X.63025-51","first-page":"511","volume-title":"Papillary Thyroid Carcinoma: 10 year follow up report of the impact of therapy in 576 patients","author":"Mazzaferri","year":"1981","journal-title":"Am J Med"},{"key":"key-10.4103\/0019-509X.63025-52","first-page":"414","volume-title":"Natural History, treatment, and course of Papillary Thyroid Carcinoma","author":"DeGroot","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-53","first-page":"714","volume-title":"The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients","author":"Samaan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-54","first-page":"474","volume-title":"Differentiated thyroid cancer presenting initially with distant metastasis","author":"Shaha","year":"1997","journal-title":"Am J Surg"},{"key":"key-10.4103\/0019-509X.63025-55","first-page":"419","volume-title":"Differentiated thyroid cancer: Re-examination of risk groups and out come of treatment","author":"Sanders","year":"1998","journal-title":"Arch Surg"},{"key":"key-10.4103\/0019-509X.63025-56","doi-asserted-by":"crossref","unstructured":"Alvarado R, Sywak MS, Delbridge L, Sidhu SB. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Surgery 2009;145:514-8. Epub 2009 Mar 27.","DOI":"10.1016\/j.surg.2009.01.013"},{"key":"key-10.4103\/0019-509X.63025-57","first-page":"1313","volume-title":"Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter.An evidence-based review?","author":"Agarwal","year":"2008","journal-title":"World J Surg"},{"key":"key-10.4103\/0019-509X.63025-58","first-page":"381","volume-title":"An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid","author":"Ito","year":"2003","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-59","first-page":"279","volume-title":"Treatment for microcarcinoma of the thyroid-clinical experience","author":"K\u03cc\u03b7\u03cck","year":"2007","journal-title":"Clin Nucl Med"},{"key":"key-10.4103\/0019-509X.63025-60","first-page":"1144","volume-title":"Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients","author":"Pelizzo","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"key-10.4103\/0019-509X.63025-61","first-page":"747","volume-title":"Papillary microcarcinoma","author":"Noguchi","year":"2008","journal-title":"World J Surg"},{"key":"key-10.4103\/0019-509X.63025-62","first-page":"980","volume-title":"Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period","author":"Hay","year":"2008","journal-title":"Surgery"},{"key":"key-10.4103\/0019-509X.63025-63","first-page":"1056","volume-title":"Increased incidence of thyroid carcinoma in France: A true epidemic or thyroid nodule management effects.Report from the French Thyroid Cancer Committee?","author":"Leenhardt","year":"2004","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-64","first-page":"489","volume-title":"Value of Preoperative Ultrasonography in the Surgical Management of Initial and Reoperative Papillary Thyroid Cancer","author":"Stulak","year":"2006","journal-title":"Arch Surg"},{"key":"key-10.4103\/0019-509X.63025-65","first-page":"340","volume-title":"Lymphadenectomy for Papillary Thyroid Cancer: Changes in practice over four decades","author":"Palazzo","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"key-10.4103\/0019-509X.63025-66","first-page":"333","volume-title":"Neck dissection for surgical treatment of lymph node metastasis in papillary thyroid carcinoma","author":"Ducci","year":"1997","journal-title":"J Exp Clin Cancer Res"},{"key":"key-10.4103\/0019-509X.63025-67","first-page":"1000","volume-title":"Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer","author":"Sywak","year":"2006","journal-title":"Surgery"},{"key":"key-10.4103\/0019-509X.63025-68","first-page":"807","volume-title":"Radioiodine in the treatment of thyroid cancer","author":"Nostrand","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/0019-509X.63025-69","first-page":"501","volume-title":"Thyroid carcinoma","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"key-10.4103\/0019-509X.63025-70","first-page":"414","volume-title":"Natural history, treatment, and course of papillary thyroid carcinoma","author":"DeGroot","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-71","first-page":"622","volume-title":"Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma","author":"Taylor","year":"1998","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0019-509X.63025-72","first-page":"741","volume-title":"Ablative radioactive iodine therapy for apparently localized thyroid carcinoma: A decision analytic perspective","author":"Wong","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/0019-509X.63025-73","first-page":"960","volume-title":"Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma","author":"Schlumberger","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-74","first-page":"734","volume-title":"Influence of triiodothyronine withdrawal time on 131I uptake post- thyroidectomy for thyroid cancer","author":"Goldman","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-75","first-page":"866","volume-title":"A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer","author":"Lakshmanan","year":"1988","journal-title":"Clin Nucl Med"},{"key":"key-10.4103\/0019-509X.63025-76","first-page":"629","volume-title":"Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma","author":"Sherman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-77","first-page":"1546","volume-title":"Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma","author":"Muratet","year":"1998","journal-title":"J Nucl Med"},{"key":"key-10.4103\/0019-509X.63025-78","first-page":"6","volume-title":"Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer","author":"Mandel","year":"2001","journal-title":"Clin Nucl Med"},{"key":"key-10.4103\/0019-509X.63025-79","unstructured":"British Thyroid Association and Royal College of Physicians. Guidelines for the management of thyroid cancer in adults London: Guidelines for the management of thyroid cancer in adults."},{"key":"key-10.4103\/0019-509X.63025-80","first-page":"1127","volume-title":"Radioiodine ablation of residual tissue in thyroid cancer: Relationship between administered activity, neck uptake and outcome","author":"Logue","year":"1994","journal-title":"Br J Radiol"},{"key":"key-10.4103\/0019-509X.63025-81","first-page":"2574","volume-title":"Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma","author":"Bal","year":"1996","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.63025-82","first-page":"1287","volume-title":"An analysis of ablation of thyroid remnants with I-131 in 511 patients from 1947-1984: Experience at University of Michigan","author":"Beierwaltes","year":"1984","journal-title":"J Nucl Med"},{"key":"key-10.4103\/0019-509X.63025-83","first-page":"1132","volume-title":"Radioiodine-131 therapy for well-differentiated thyroid cancer-a quantitative radiation dosimetric approach: Outcome and validation in 85 patients","author":"Maxon","year":"1992","journal-title":"J Nucl Med"},{"key":"key-10.4103\/0019-509X.63025-84","first-page":"281","volume-title":"Percent 131I uptake and post-therapy 131I scans: Their role in the management of thyroid cancer","author":"Reynolds","year":"1997","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-85","first-page":"945","volume-title":"Surveillance of patients to detect recurrent thyroid carcinoma","author":"Grigsby","year":"1999","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.63025-86","first-page":"737","volume-title":"Thyroid suppression and disease progression in patients with well differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry","author":"Cooper","year":"1998","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-87","first-page":"2165","volume-title":"Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer","author":"Singer","year":"1996","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0019-509X.63025-88","first-page":"97","volume-title":"Controversies in the follow-up and management of well-differentiated thyroid cancer","author":"Ringel","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0019-509X.63025-89","first-page":"787","volume-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","author":"Pacini","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0019-509X.63025-90","first-page":"241","volume-title":"Managing patients with papillary thyroid carcinoma: Insights gained from the Mayo Clinic\u2032s experience of treating 2,512 consecutive patients during 1940 through 2000","author":"Hay","year":"2002","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"key-10.4103\/0019-509X.63025-91","first-page":"1447","volume-title":"Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer","author":"Mazzaferri","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-92","first-page":"860","volume-title":"Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma","author":"Simon","year":"1996","journal-title":"World J Surg"},{"key":"key-10.4103\/0019-509X.63025-93","first-page":"249","volume-title":"Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma","author":"Schlumberger","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0019-509X.63025-94","first-page":"976","volume-title":"Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer","author":"M\u03ccller-G\u03b4rtner","year":"1988","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.63025-95","first-page":"3877","volume-title":"A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer","author":"Haugen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-96","first-page":"435","volume-title":"Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement","author":"Spencer","year":"1999","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-97","first-page":"429","volume-title":"Strategies for thyrotropin use to monitor patients with treated thyroid carcinoma","author":"Ladenson","year":"1999","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-98","first-page":"1433","volume-title":"A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma","author":"Mazzaferri","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-99","first-page":"25","volume-title":"Role of neck ultrasonography in the followup of patients operated on for thyroid cancer","author":"Antonelli","year":"1995","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-100","first-page":"446","volume-title":"Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma","author":"Franceschi","year":"1996","journal-title":"J Nucl Med"},{"key":"key-10.4103\/0019-509X.63025-101","first-page":"45","volume-title":"Sonography in the followup of 100 patients with thyroid carcinoma","author":"Simeone","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"key-10.4103\/0019-509X.63025-102","first-page":"267","volume-title":"Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the followup of patients with differentiated thyroid carcinoma","author":"David","year":"2005","journal-title":"Thyroid"},{"key":"key-10.4103\/0019-509X.63025-103","first-page":"540","volume-title":"Current Concepts in the Follow-Up of Patients with Differentiated Thyroid Cancer","author":"Benbassat","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"key-10.4103\/0019-509X.63025-104","first-page":"3242","volume-title":"Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?","author":"Robbins","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-105","first-page":"4435","volume-title":"Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood","author":"Ringel","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-106","first-page":"3135","volume-title":"Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy","author":"Karavitaki","year":"2005","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0019-509X.63025-107","first-page":"33","volume-title":"Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients","author":"Elisei","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-108","first-page":"169","volume-title":"Positron emission tomography in thyroid cancer management","author":"Larson","year":"2002","journal-title":"Semin Roentgenol"},{"key":"key-10.4103\/0019-509X.63025-109","first-page":"78","volume-title":"The value of FDG-PET in the follow-up differentiated thyroid cancer: A review of the literature","author":"Stokkel","year":"2006","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"key-10.4103\/0019-509X.63025-110","first-page":"2892","volume-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy","author":"Durante","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-509X.63025-111","first-page":"645","volume-title":"RET\/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture","author":"Santoro","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0019-509X.63025-112","first-page":"249","volume-title":"How thyroid tumors start and why it matters: Kinase mutants as targets for solid cancer pharmacotherapy","author":"Fagin","year":"2004","journal-title":"J Endocrinol"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:51:15Z","timestamp":1786632675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-509X.63025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"alternative-id":["63025"],"URL":"https:\/\/doi.org\/10.4103\/0019-509x.63025","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}